George joined Royalty Pharma in 2020. Previously, he served as VP, Head of Global Investor Relations at Sanofi. Prior to joining Sanofi, George was the senior equity research analyst at Citi covering the US large-cap pharmaceutical industry. He is a CFA®charterholder and holds a BS in accounting from Binghamton University.
